Behavioral Neurology and Neuropsychiatry Fellowship

The Behavioral Neurology and Neuropsychiatry Fellowship at the Nantz National Alzheimer Center of Houston Methodist Neurological Institute was accredited in 2020 by the United Council for Neurological Subspecialties and received full re-accreditation June 1, 2025. A partnership between the Departments of Neurology and Psychiatry of Houston Methodist Hospital allows for fellows to acquire experience in the diagnosis and management of a variety of disorders including but not limited to:

• Alzheimer’s disease
• Frontotemporal dementia
• Lewy-Body dementia
• Vascular cognitive disorder
• Cognitive effects of epilepsy
• Traumatic brain injury
• Synaptic autoantibody disorders

The Program is comprised of clinical training (evaluation, diagnosis, treatment, systems-based practice), exposure to groundbreaking research programs (study design and execution, publications, grant writing), and other scholarly activities (education opportunities). The foundations of these individual experiences is an extensive patient population, excellent clinical and research facilities and the expertise and experience of our Director, Dr. Joseph C. Masdeu, MD, PhD and the core faculty dedicated to training our fellows in each area with flexibility to tailor the program to each fellows desired goals and future aspirations within the subspecialty.

Emphasis is given to the correlation of the clinical syndrome with anatomic imaging provided by MRI and molecular imaging with PET, including tracers for amyloid, tau, inflammation and cholinergic activity. Dr. Masdeu is Co-Director of a UCNS-approved Neuroimaging Fellowship.

The fellowship program is expected to be completed in a 12-month program with monthly rotations, beginning either July 1st or August 1st of each year.

Candidates are required to have successfully completed an accredited residency program in neurology or behavioral psychiatry before the start of the fellowship.   

Required documentation:

• Updated CV
• Three (3) letters of recommendation
• One (1) letter of good standing from your current residency program
  
  

Interviews are by invitation only. 

Drug & Tobacco Screening: Applicants will be tested for nicotine and drug usage during the post-offer physical. If an applicant tests positive for nicotine use, including nicotine gum and patches, the offer will be rescinded, and individuals will be given the opportunity to participate in a free Houston Methodist-provided tobacco cessation program. Applicants wishing to reapply after testing positive for nicotine may do so 90 days after the date the initial offer was rescinded.

If the applicant tests positive for drug use, the offer will be rescinded. Job seekers wishing to reapply after testing positive in the drug screening may do so one year after the date the initial offer was rescinded.

Background Check: Prior to employment start date, job seekers must complete a criminal background check.